Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
Study NCT ID:
NCT01290718
Status:
TERMINATED
Last Update Posted:
2014-12-17
First Post:
2011-02-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-03
First Submit QC Date:
None
Study First Post Date:
2011-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-03
Results First Submit QC Date:
None
Results First Post Date:
2014-12-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-12-15
Last Update Post Date:
2014-12-17
Last Update Post Date Type:
ESTIMATED